This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignee: North Carolina State University. Active years: 2008-2010.
Location History:
- Apex, NC (US) (2008 - 2009)
- Palmerston, NZ (2010)
Company Filing History:
Years Active: 2008-2010
Title: Eric Altermann: Innovator in Nucleic Acid Technologies
Introduction
Eric Altermann is a prominent inventor based in Apex, NC (US), known for his significant contributions to the field of nucleic acid technologies. With a total of 8 patents to his name, Altermann has made notable advancements that have implications in various scientific applications.
Latest Patents
Among his latest patents, Altermann has developed innovative nucleic acids encoding fructo-oligosaccharide utilization compounds. This invention includes FOS-related protein nucleic acid molecules, polypeptides, and their fragments and variants. Additionally, it encompasses FOS-related fusion proteins, antigenic peptides, and anti-FOS-related antibodies. The invention also provides recombinant expression vectors containing these nucleic acid molecules and host cells that have been introduced to the expression vectors. Furthermore, methods for producing the polypeptides and their applications are disclosed.
Another significant patent involves stress-related nucleic acid molecules and polypeptides, including their fragments and variants. This invention also covers stress-related fusion proteins, antigenic peptides, and anti-stress-related antibodies. Similar to his previous work, it provides recombinant expression vectors and host cells for these nucleic acid molecules, along with methods for producing the polypeptides and their uses.
Career Highlights
Eric Altermann is affiliated with North Carolina State University, where he continues to engage in research and innovation. His work has been instrumental in advancing the understanding of nucleic acids and their applications in biotechnology.
Collaborations
Throughout his career, Altermann has collaborated with notable colleagues, including Todd Robert Klaenhammer and W. Michael Russell. These collaborations have further enriched his research and contributed to the scientific community.
Conclusion
Eric Altermann stands out as a key figure in the field of nucleic acid technologies, with a strong portfolio of patents that reflect his innovative spirit and dedication to scientific advancement. His contributions continue to influence research and applications in biotechnology.